These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36389774)

  • 41. Exploring the therapeutic potential of endolysin CD27L_EAD against Clostridioides difficile infection.
    Cho Y; Park K; Park J; An J; Myung H; Yoon H
    Int J Antimicrob Agents; 2024 Aug; 64(2):107222. PubMed ID: 38810936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
    Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
    J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bacteriophage endolysins as a potential weapon to combat
    Mondal SI; Draper LA; Ross RP; Hill C
    Gut Microbes; 2020 Nov; 12(1):1813533. PubMed ID: 32985336
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
    Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
    Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation.
    Gonzales-Luna AJ; Spinler JK; Oezguen N; Khan MAW; Danhof HA; Endres BT; Alam MJ; Begum K; Lancaster C; Costa GP; Savidge TC; Hurdle JG; Britton R; Garey KW
    Anaerobe; 2021 Aug; 70():102387. PubMed ID: 34044101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Faecal microbiota transplantation for treatment of recurrent or refractory
    Lui RN; Wong SH; Lau LHS; Chan TT; Cheung KCY; Li A; Chin ML; Tang W; Ching JYL; Lam KLY; Chan PKS; Wu JCY; Sung JJY; Chan FKL; Ng SC
    Hong Kong Med J; 2019 Jun; 25(3):178-182. PubMed ID: 31178437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
    Juszczuk K; Grudlewska K; Mikucka A; Gospodarek E
    Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):220-226. PubMed ID: 28345530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in
    Khanna S
    Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1067-1070. PubMed ID: 33427531
    [No Abstract]   [Full Text] [Related]  

  • 49. [Transplantation of fecal matter in octogenarian patients with recurrent Clostridioides difficile infection].
    Quera R; Sedano R; Espinoza R; Rivera D
    Rev Chilena Infectol; 2019 Aug; 36(4):536-540. PubMed ID: 31859781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.
    Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T
    J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fecal Microbiota Transplantation: The Evolving Risk Landscape.
    Gupta S; Mullish BH; Allegretti JR
    Am J Gastroenterol; 2021 Apr; 116(4):647-656. PubMed ID: 33982930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.
    Hui W; Li T; Liu W; Zhou C; Gao F
    PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Faecal microbiota transplantation for eradication of co-infection with
    Bahl MI; Jørgensen SMD; Skriver AH; Larsen NA; Wang M; Licht TR; Dahlerup JF; Hvas CL
    Scand J Gastroenterol; 2020 May; 55(5):626-630. PubMed ID: 32324085
    [No Abstract]   [Full Text] [Related]  

  • 54. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
    Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
    Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of failure after fecal microbiota transplantation for recurrent Clostridioides difficile infection: a systematic review and meta-analysis.
    Tariq R; Hayat M; Pardi D; Khanna S
    Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1383-1392. PubMed ID: 33496893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent developments in the management of recurrent Clostridioides difficile infection.
    Mendo-Lopez R; Villafuerte-Gálvez J; White N; Mahoney MV; Kelly CP; Alonso CD
    Anaerobe; 2020 Apr; 62():102108. PubMed ID: 31606481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
    Nooij S; Ducarmon QR; Laros JFJ; Zwittink RD; Norman JM; Smits WK; Verspaget HW; Keller JJ; Terveer EM; Kuijper EJ;
    Gastroenterology; 2021 Oct; 161(4):1218-1228.e5. PubMed ID: 34126062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.
    Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
    Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.